By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Castle Biosciences 

Houston  Texas    U.S.A.
Phone: n/a Fax: n/a



Company News
Castle Biosciences’ Uveal Melanoma Test Receives Positive Medicare Local Coverage Determination And Commercial Insurance Positive Coverage Policies 7/18/2017 8:18:01 AM
Castle Biosciences Presents Three New Clinical Studies At ASCO 2017 Highlighting The Accuracy And Performance Of The Decisiondx-Melanoma Gene Expression Profile Test For Cutaneous Melanoma 6/5/2017 9:01:52 AM
Castle Biosciences Release: Study Demonstrates Significant And Risk-Appropriate Clinical Impact Of DecisionDx-Melanoma Test Results On Patient Management Decisions 5/15/2017 8:55:39 AM
Oxford Finance And Silicon Valley Bank Close $20 Million Credit Facility With Castle Biosciences 5/11/2017 8:04:42 AM
Castle Biosciences’ Decisiondx-Melanoma Test Accurately Predicts Metastatic Risk In Patients With Head And Neck Melanoma 5/1/2017 8:08:39 AM
Blue Cross Blue Shield Association Evidence Street Issues Positive Assessment Of Castle Biosciences’ Uveal Melanoma Gene Expression Test 3/29/2017 6:30:10 AM
Castle Biosciences Release: Study Demonstrates That Decisiondx-Melanoma Test Improves Identification Of High Risk Skin Melanoma When Used With AJCC Outcome Prediction Tool 1/23/2017 7:52:01 AM
Castle Biosciences Release: New Laboratory Receives Accreditation From College of American Pathologists 1/17/2017 7:46:20 AM
Castle Biosciences Announces Launch Of New Eye Cancer Test To Measure Expression Of PRAME Gene 10/10/2016 11:19:52 AM
Study Results With Castle Biosciences’ Uveal Melanoma Gene Expression Test Published In Journal Of Oncology 8/10/2016 12:35:43 PM